FMI
VRDN icon

F/M Investments’s Viridian Therapeutics VRDN Stock Holding History

F/M Investments’s Portfolio VRDN Stock Details VRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.48M Buy
+134,761
New +$2.17M 0.13% 114

Other funds holding VRDN

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
JSSH
J. Safra Sarasin Holding $6.97B AUM 32.91% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
FISPB
Fideuram - Intesa Sanpaolo Private Banking Turin $3.33B AUM

F/M Investments's VRDN Position: Q2 2026 in Review

F/M Investments opened a new position in Viridian Therapeutics (VRDN) in Q2 2026: 134,761 shares worth $2.48M. The stake represents 0.13% of the portfolio and ranks #114 among its holdings.

44 funds tracked by Wall St. Rank hold VRDN as of Q2 2026.

  • F/M Investments held 134,761 shares of Viridian Therapeutics worth $2.48M as of Q2 2026.
  • Viridian Therapeutics was a new F/M Investments position in Q2 2026.
  • Viridian Therapeutics made up 0.13% of F/M Investments's portfolio in Q2 2026, its #114 holding.
  • 44 funds tracked by Wall St. Rank held Viridian Therapeutics as of Q2 2026.

Based on F/M Investments's 13F filing for Q2 2026, filed 5 Aug 2026.